{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Familial tumour syndromes of the central and peripheral nervous system",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_temozolomide",
          "name": "Temozolomide"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_dexamethasone",
          "name": "Dexamethasone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_pemetrexed",
          "name": "Pemetrexed"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_lapatinib",
          "name": "Lapatinib"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_carmustine",
          "name": "Carmustine"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_trametinib",
          "name": "Trametinib"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_anaplastic_lymphoma_kinase_inhibitor",
          "name": "Anaplastic lymphoma kinase inhibitor"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_etoposide",
          "name": "Etoposide"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_vincristine",
          "name": "Vincristine"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_nivolumab",
          "name": "Nivolumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_atezolizumab",
          "name": "Atezolizumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_bevacizumab",
          "name": "Bevacizumab"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ta1",
          "type": "Target",
          "label": "Methylated O(6)-methylguanine-DNA methyltransferase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ta2",
          "type": "Target",
          "label": "Vascular endothelial growth factor receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pb1",
          "type": "Pathway",
          "label": "DNA damage response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pb2",
          "type": "Pathway",
          "label": "Angiogenesis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_dis",
          "type": "Disease",
          "label": "Familial tumour syndromes of the central and peripheral nervous system",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_temozolomide",
          "target": "n_ta1",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Established efficacy in brain tumors."
        },
        {
          "source": "drug_dexamethasone",
          "target": "n_ta2",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Commonly used for neuro-oncological conditions."
        },
        {
          "source": "n_ta1",
          "target": "n_pb1",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Mechanism through DNA repair inhibition."
        },
        {
          "source": "n_ta2",
          "target": "n_pb2",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Role in promoting vascular growth."
        },
        {
          "source": "n_pb1",
          "target": "n_dis",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Pathological link established."
        },
        {
          "source": "n_pb2",
          "target": "n_dis",
          "relation": "causes",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Angiogenesis contributes to tumor progression."
        },
        {
          "source": "drug_temozolomide",
          "target": "H1",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Mechanism aligns with disease treatment."
        },
        {
          "source": "drug_dexamethasone",
          "target": "H2",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Mechanism aligns with disease management."
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "Temozolomide and Dexamethasone target key pathways in tumorigenesis associated with familial syndromes.",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物具备到达相关组织的最小暴露（常识判断）"
    ],
    "uncertainties": [
      "药物可能的副作用和患者适用性需进一步验证。"
    ],
    "next_focus_for_pi": [
      "是否需要探讨其他靶点和通路以弥补现有链条？"
    ]
  }
}